U.S. markets open in 5 hours 39 minutes

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Precio en tiempo real. Moneda en USD.
Añadir a la lista de seguimiento
1.0000-0.2000 (-16.67%)
Al cierre: 04:00PM EDT
1.0400 +0.04 (+4.00%)
Fuera de horario: 07:03PM EDT

Transacciones de miembros de la gerencia

Moneda en USD
Compras de miembros de la gerencia en los últimos 6 mesesAccionesTrans
Compras00
VentasN/D0
Acciones netas compradas (vendidas)00
Acciones totales pertenecientes a miembros de la gerencia16.57MN/D
Acciones netas compradas (vendidas) en %N/DN/D
Compras institucionales netas del trimestre anterior al últimoAcciones
Acciones netas compradas (vendidas)N/D
Cambio en acciones institucionales propias en %N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerenciaTransacciónTipoValorFechaAcciones

SCHUETZ THOMAS J
Officer and Director

Stock Award(Grant) at price 1.93 per share.Directo1,230,37509 ene 2024637,500

BISKER-LEIB VERED
Chief Executive Officer

Stock Award(Grant) at price 1.93 per share.Directo3,383,53109 ene 20241,753,125

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 3.37 per share.Directo33,70010 mar 202310,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 3.98 per share.Directo79,60027 feb 202320,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 3.86 per share.Directo77,20015 feb 202320,000

SCHUETZ THOMAS J
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Directo008 feb 2023500,000

BISKER-LEIB VERED
Chief Operating Officer

Stock Award(Grant) at price 0.00 per share.Directo008 feb 2023400,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 4.05 per share.Directo81,00031 ene 202320,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 4.19 per share.Directo83,80024 ene 202320,000

BISKER-LEIB VERED
Chief Operating Officer

Sale at price 4.19 - 4.36 per share.Directo103,70825 nov 202224,500

BISKER-LEIB VERED
Chief Operating Officer

Sale at price 4.34 - 4.40 per share.Directo96,98621 nov 202222,261

ORBIMED ADVISORS, L.L.C.
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 4.25 per share.Indirecto1,708,50008 nov 2022402,000

GORDON CARL L
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 4.25 per share.Indirecto1,708,50008 nov 2022402,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.32 per share.Directo23,20028 sept 202210,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.27 per share.Directo34,05026 sept 202215,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 3.03 per share.Directo45,45007 sept 202215,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.83 per share.Directo42,45001 sept 202215,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 3.05 per share.Directo45,75017 ago 202215,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.64 per share.Directo39,60010 ago 202215,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.58 per share.Directo38,70001 ago 202215,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.80 per share.Directo56,00021 jun 202220,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.34 per share.Directo46,80016 jun 202220,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.29 per share.Directo68,70013 jun 202230,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.83 per share.Directo84,90006 jun 202230,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 3.03 per share.Directo60,60001 jun 202220,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 3.04 per share.Directo60,80026 may 202220,000

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.72 per share.Directo49,92623 may 202218,355

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 2.47 per share.Directo49,93117 may 202220,215

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 1.79 - 2.49 per share.Indirecto420,48213 may 2022192,516

GORDON CARL L
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 1.79 - 2.49 per share.Indirecto420,48213 may 2022192,516

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 1.56 - 1.63 per share.Indirecto197,25210 may 2022125,359

GORDON CARL L
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 1.56 - 1.63 per share.Indirecto197,25210 may 2022125,359

SCHUETZ THOMAS J
Chief Executive Officer

Purchase at price 1.80 per share.Directo50,10510 may 202227,836

SCHUETZ THOMAS J
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Directo016 nov 2021600,000

BISKER-LEIB VERED
Chief Operating Officer

Stock Award(Grant) at price 0.00 per share.Directo016 nov 2021600,000

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 3.50 per share.Indirecto18,750,00004 nov 20215,357,143

GORDON CARL L
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 3.50 per share.Indirecto18,750,00004 nov 20215,357,143